Insulin aspart was given at mealtimes. Insulin secretagogues and a-glucosidase inhibitors were discontinued at study entry, and existing OADs were continued. Doses of detemir and glargine were titrated to achieve a prebreakfast (and predinner for detemir administered twice daily) pl...
tachycardiaandevencoma.(2)insulinresistance,thedailydoserequiredmorethan200unitsormore.3injectionsitelipoatrophy,fathyperplasia.4refractivedisorders.DosageThisproductthansolublehumaninsulinfasteronset,shorterdurationofaction,duetotherapidonset,itisgenerallyrequiredbeforeamealnextinjection.Ifnecessary,administeredimmediately...
administered much closer to meal times (5–15 min before meals) in the treatment of diabetes using “basal-bolus” regimens, in which basal insulin concentrations are provided by long-acting insulin preparations and bolus injections of rapid onset, short-acting insulins are given with each meal....
Fiasp®can be administered using the FlexTouch®pen, the vial and a syringe, the vial and an insulin pump, the PenFill®cartridge and a durable pen, and PumpCart®for use with compatible pump. Which will you choose for your patients?
the mannerin which insulin is administered under the condition that the pump is uniqueand simulates non feeding. - 1 calculation of basicquantities - 2 how to set the foundationon the pump - 3, the foundation of thepump is set correctly or not to be tested, and its detection is carried...
Insulin degludec/insulin aspart administered once daily at any meal, with insulin aspart at other meals versus a standard basal-bolus regimen in patients ... IB Hirsch,B Bode,JP Courreges,... - 《Diabetes Care》 被引量: 86发表: 2012年 Insulin Degludec/Insulin Aspart Administered Once Daily ...
include changes in meal pattern (e.g., macronutrient content or timing of meals), changes in level of physical activity, or changes to co-administered medication [seeDRUG INTERACTIONS]. Patients with renal or hepatic impairment may be at higher risk of hypoglycemia [seeUse In Specific ...
Short-acting insulin formulations are administered before meal to control the postprandial hyperglycemia. The injected insulin at the subcutaneous tissue exists as hexamers. The size of hexamers is too large to enter into the capillaries. The insulin hexamers dissociate slowly into dimers and monomers ...
With such a system, the physician usually fixes the basal dosage based upon the patient's previous insulin requirements. The patient usually has relatively free control over the bolus dosage administered at mealtimes. More or less insulin may be taken, depending upon the size of the meal anticip...
Hypoglycemia reported and may be life-threatening; increased frequency of glucose monitoring with changes to insulin dosage, coadministered glucose-lowering medications, meal pattern, and physical activity; and in patients with renal or hepatic impairment and hypoglycemia unawareness ...